Effectiveness and Safety of Lenvatinib Combined With Chinese Herbal Medicine for Patients With Unresectable Hepatocellular Carcinoma: A Real-world Study in China
Clinical trial NCT06315101 · COMPLETED
Trial details
- NCT number
- NCT06315101
- Sponsor
- Guangzhou University of Chinese Medicine
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-01
- Primary completion
- 2023-12-31
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.